Search Results Search Sort by RelevanceMost Recent AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611. Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611. State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611. Policy Forum Nov 2016 Transgender Reproductive Choice and Fertility Preservation Khadija Mitu, PhD Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment. AMA J Ethics. 2016;18(11):1119-1125. doi: 10.1001/journalofethics.2016.18.11.pfor2-1611. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611.
Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611.
State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611.
Policy Forum Nov 2016 Transgender Reproductive Choice and Fertility Preservation Khadija Mitu, PhD Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment. AMA J Ethics. 2016;18(11):1119-1125. doi: 10.1001/journalofethics.2016.18.11.pfor2-1611.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.